NO20054296L - Anvendelse av palonosetron for behandling av kvalme og oppkast etter kirurgisk inngrep - Google Patents

Anvendelse av palonosetron for behandling av kvalme og oppkast etter kirurgisk inngrep

Info

Publication number
NO20054296L
NO20054296L NO20054296A NO20054296A NO20054296L NO 20054296 L NO20054296 L NO 20054296L NO 20054296 A NO20054296 A NO 20054296A NO 20054296 A NO20054296 A NO 20054296A NO 20054296 L NO20054296 L NO 20054296L
Authority
NO
Norway
Prior art keywords
vomiting
palonosetron
treatment
nausea
surgery
Prior art date
Application number
NO20054296A
Other languages
English (en)
Norwegian (no)
Other versions
NO20054296D0 (no
Inventor
Alberto Macciocch
Ricardo Braglia
Enrico Braglia
Luigi Baroni
Original Assignee
Helsinn Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32908576&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20054296(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Helsinn Healthcare Sa filed Critical Helsinn Healthcare Sa
Publication of NO20054296D0 publication Critical patent/NO20054296D0/no
Publication of NO20054296L publication Critical patent/NO20054296L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20054296A 2003-02-18 2005-09-16 Anvendelse av palonosetron for behandling av kvalme og oppkast etter kirurgisk inngrep NO20054296L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44834203P 2003-02-18 2003-02-18
PCT/EP2004/001558 WO2004073714A1 (en) 2003-02-18 2004-02-18 Use of palonosetron treating post-operative nausea and vomiting

Publications (2)

Publication Number Publication Date
NO20054296D0 NO20054296D0 (no) 2005-09-16
NO20054296L true NO20054296L (no) 2005-11-17

Family

ID=32908576

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054296A NO20054296L (no) 2003-02-18 2005-09-16 Anvendelse av palonosetron for behandling av kvalme og oppkast etter kirurgisk inngrep

Country Status (32)

Country Link
US (1) US20060074101A1 (xx)
EP (2) EP1596862B1 (xx)
JP (1) JP2006517944A (xx)
KR (1) KR101113087B1 (xx)
CN (1) CN1750822A (xx)
AT (1) ATE490774T1 (xx)
AU (1) AU2004212704B2 (xx)
BR (1) BRPI0407549A (xx)
CA (1) CA2515946C (xx)
CU (1) CU23587B7 (xx)
CY (1) CY1111312T1 (xx)
DE (1) DE602004030424D1 (xx)
DK (1) DK1596862T3 (xx)
EA (1) EA013836B1 (xx)
EC (1) ECSP055970A (xx)
ES (1) ES2357769T3 (xx)
GE (1) GEP20104908B (xx)
HK (1) HK1076402A1 (xx)
HR (1) HRP20050709A2 (xx)
IS (1) IS7983A (xx)
MX (1) MXPA05008757A (xx)
MY (1) MY143789A (xx)
NO (1) NO20054296L (xx)
NZ (1) NZ541862A (xx)
PL (1) PL378122A1 (xx)
PT (1) PT1596862E (xx)
SI (1) SI1596862T1 (xx)
TW (1) TWI355936B (xx)
UA (1) UA96254C2 (xx)
UY (1) UY28193A1 (xx)
WO (1) WO2004073714A1 (xx)
ZA (1) ZA200506580B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2282299T3 (es) 2000-10-20 2007-10-16 EISAI R&D MANAGEMENT CO., LTD. Compuestos aromaticos con anillos de nitrogeno como agentes anticancerigenos.
WO2004045615A1 (en) * 2002-11-15 2004-06-03 Helsinn Healthcare Sa Palonosetron for the treatment of chemotherapy-induced emesis
JO2735B1 (en) 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
CN103211779B (zh) * 2006-01-27 2016-03-16 阿代尔制药股份有限公司 包含弱碱性选择性5-羟色胺5-ht3阻断剂和有机酸的药物递送系统
ES2533563T5 (es) * 2006-01-27 2018-07-24 Adare Pharmaceuticals, Inc. Sistemas de suministro de fármacos que comprenden fármacos débilmente básicos y ácidos orgánicos
EP1940366B9 (en) * 2006-10-24 2009-12-02 Helsinn Healthcare S.A. Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability
TWI429436B (zh) * 2007-04-10 2014-03-11 Helsinn Therapeutics Us Inc 使用生長激素促泌素治療或預防嘔吐之方法
US20090155363A1 (en) * 2007-12-14 2009-06-18 Todd Maibach Methods for oral administration of active drugs
JP5547065B2 (ja) 2008-05-15 2014-07-09 久光製薬株式会社 パロノセトロンを含有する経皮吸収製剤
US20100143461A1 (en) * 2008-12-08 2010-06-10 Ben-Zion Solomon Palonosetron formulation
ES2664599T3 (es) 2009-05-20 2018-04-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Antagonistas del receptor 5-HT3 de serotonina para uso en el tratamiento de trastornos vestibulares lesionales
ES2432618T3 (es) * 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
US20110003005A1 (en) * 2009-07-06 2011-01-06 Gopi Venkatesh Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
CN102781939A (zh) 2009-11-13 2012-11-14 赫尔辛医疗股份公司 帕洛诺司琼代谢物
EP2722045B1 (en) 2009-11-18 2016-07-06 Helsinn Healthcare SA Compositions for treating centrally mediated nausea and vomiting
EA026815B1 (ru) * 2009-11-18 2017-05-31 Хелсинн Хелткэа Са Пероральная лекарственная форма, содержащая палоносетрон и нетупитант, капсульная лекарственная форма, способ лечения тошноты и рвоты
KR101368587B1 (ko) * 2010-12-27 2014-03-05 주식회사 삼양바이오팜 오심 또는 구토 방지용 조성물
WO2014004126A1 (en) 2012-06-26 2014-01-03 Fleming C Andrew Treating postoperative nausea and vomiting
KR20150073866A (ko) 2013-12-23 2015-07-01 주식회사 삼양바이오팜 팔로노세트론을 함유하는 약학 조성물
DK3442537T3 (da) 2016-04-14 2024-03-25 Sensorion (+)-azasetron til anvendelse i behandlingen af ørelidelser
JP6768404B2 (ja) * 2016-08-12 2020-10-14 武田テバファーマ株式会社 パロノセトロン又はその薬学的に許容される塩を含む医薬組成物
JP6705348B2 (ja) * 2016-09-23 2020-06-03 ニプロ株式会社 液体製剤、及び、パロノセトロンの安定性を向上する方法
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
KR101802183B1 (ko) * 2016-11-16 2017-11-28 주식회사 유영제약 팔로노세트론을 활성성분으로 함유하는 약제학적 조성물
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method
HUE062180T2 (hu) 2018-01-12 2023-09-28 Orion Corp Palonosetron szemcsepp a hányinger és a hányás kezelésére vagy megelõzésére
CN108703960A (zh) * 2018-07-25 2018-10-26 无锡鑫连鑫生物医药科技有限公司 一种帕洛诺司琼缓释微球及其制备方法和使用方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
EP0200444B1 (en) 1985-04-27 1992-11-11 Beecham Group Plc Azabicyclononyl-indazole-carboxamide having 5-ht antagonist activity
US4937247A (en) 1985-04-27 1990-06-26 Beecham Group P.L.C. 1-acyl indazoles
GB8516083D0 (en) 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
US5240954A (en) 1985-06-25 1993-08-31 Glaxo Group Limited Medicaments
US5578628A (en) 1985-06-25 1996-11-26 Glaxo Group Limited Medicaments for the treatment of nausea and vomiting
US4906755A (en) 1986-11-03 1990-03-06 Merrell Dow Pharmaceuticals Inc. Esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3-(4H)-one and related compounds
US4707484A (en) 1986-11-25 1987-11-17 Hoffmann-La Roche Inc. Substituted piperidinomethylindolone and cyclopent(b)indolone derivatives
US5011846A (en) 1988-02-23 1991-04-30 Merrell Dow Pharmaceuticals Inc. Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
US5344658A (en) * 1989-06-28 1994-09-06 Glaxo Group Limited Process and composition using ondansetron
GB8914804D0 (en) * 1989-06-28 1989-08-16 Glaxo Group Ltd Process
PT96001B (pt) 1989-11-28 1998-01-30 Syntex Inc Processo para a preparacao de derivados de isoquinolina condensada com um anel carbociclico
US5189041A (en) 1990-11-16 1993-02-23 Syntex (U.S.A.) Inc. Tricyclic 5-ht3 receptor antagonists
US5137893A (en) 1991-03-07 1992-08-11 G. D. Searle & Co. Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof
US5491148A (en) 1991-04-26 1996-02-13 Syntex (U.S.A.) Inc. Isoquinolinone and dihydroisoquinolinone 5-HT3 receptor antagonists
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
GB9305593D0 (en) 1993-03-18 1993-05-05 Smithkline Beecham Plc Pharmaceuticals
US5492914A (en) 1994-07-28 1996-02-20 Syntex (U.S.A.) Inc. 2-(1-azabicyclo[2.2.2]oct-3 s-yl)-6-hydroxy-2,4,5,6-tetrahydro-1H-benz[DE]is[2.2.2]oct-3's-yl)-6-hydroxy-2,3,3a,4,5,6-hexahydro-1h-benz [DE]isoquinolin-1-one and individual stereoisomers thereof
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9423511D0 (en) 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9625589D0 (en) * 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US6294548B1 (en) 1998-05-04 2001-09-25 Hoffmann-La Roche Inc. Multidose vial formulations for administering endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride
EP1085888A1 (en) * 1998-06-08 2001-03-28 Advanced Medicine, Inc. Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht 3? receptors
US6284749B1 (en) * 1998-10-27 2001-09-04 Alcon Manufacturing, Ltd. Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
US6196963B1 (en) * 1999-03-02 2001-03-06 Medtronic Ave, Inc. Brachytherapy device assembly and method of use
AU2003237657A1 (en) * 2002-05-24 2003-12-12 Epidauros Biotechnologie Ag Means and methods for improved treatment using "setrones"
WO2004045615A1 (en) * 2002-11-15 2004-06-03 Helsinn Healthcare Sa Palonosetron for the treatment of chemotherapy-induced emesis
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
US8598219B2 (en) * 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron

Also Published As

Publication number Publication date
EA013836B1 (ru) 2010-08-30
NZ541862A (en) 2008-04-30
NO20054296D0 (no) 2005-09-16
CU23587B7 (es) 2010-10-30
GEP20104908B (en) 2010-03-10
PT1596862E (pt) 2011-03-15
CA2515946C (en) 2008-12-02
CN1750822A (zh) 2006-03-22
EP1596862A1 (en) 2005-11-23
TW200418474A (en) 2004-10-01
SI1596862T1 (sl) 2011-03-31
AU2004212704A1 (en) 2004-09-02
CA2515946A1 (en) 2004-09-02
HK1076402A1 (en) 2006-01-20
MY143789A (en) 2011-07-15
ATE490774T1 (de) 2010-12-15
AU2004212704B2 (en) 2009-10-01
HRP20050709A2 (en) 2005-12-31
EP2258367A2 (en) 2010-12-08
EA200501318A1 (ru) 2006-02-24
KR20050121671A (ko) 2005-12-27
WO2004073714A1 (en) 2004-09-02
PL378122A1 (pl) 2006-03-06
ZA200506580B (en) 2006-06-28
KR101113087B1 (ko) 2012-02-15
CY1111312T1 (el) 2015-08-05
MXPA05008757A (es) 2006-05-31
JP2006517944A (ja) 2006-08-03
DK1596862T3 (da) 2011-03-28
UY28193A1 (es) 2004-09-30
EP2258367A3 (en) 2011-07-13
DE602004030424D1 (de) 2011-01-20
BRPI0407549A (pt) 2006-02-14
ECSP055970A (es) 2006-01-16
UA96254C2 (uk) 2011-10-25
EP1596862B1 (en) 2010-12-08
TWI355936B (en) 2012-01-11
US20060074101A1 (en) 2006-04-06
IS7983A (is) 2005-08-15
ES2357769T3 (es) 2011-04-29

Similar Documents

Publication Publication Date Title
NO20054296L (no) Anvendelse av palonosetron for behandling av kvalme og oppkast etter kirurgisk inngrep
EA200800716A1 (ru) Новая кристаллическая форма производного пиридазино[4,5-в]индола
DE602006007556D1 (de) Heteroarylsulfonylstilbene als 5-ht2a-antagonisten
NO20061112L (no) Metode og apparat for kinematisk linking av multiple seismiske domener
DE602005012634D1 (en) Arylsulfonylnaphthalinderivate als 5ht2a-antagonisten
NO20080484L (no) Niacin-reseptorantagonister, preparater inneholdende slike forbindelser og behandlingsmetoder
NO20060775L (no) Muskarine acetylkolinreseptorantagonister
NO20065417L (no) Muskarine acetylkolinreceptorantagonister
NO20070608L (no) Anvendelse av 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner ved behandling av kvalme og oppkast
SG154443A1 (en) Piperidine derivatives as nk1 antagonists
PL1831152T3 (pl) Pochodne tetraliny i indanu oraz ich zastosowanie jako antagonistów 5-HT
NO20063636L (no) Muskariniske acetylkolinrecptoorantagonister
MX2007005428A (es) Combinaciones de agonistas del receptor nicotinico alfa 7 y de la acetilcolina.
NO20080033L (no) Kinolinderivater som NK3-antagonister
NO20076681L (no) Ny metode for fremstilling av tiotropiumsalter
CA2505990A1 (en) Palonosetron for the treatment of chemotherapy-induced emesis
NO20072832L (no) Smertestillende middel
NO20083269L (no) Prosess for a anvende krystallinsk orlistatmetoder
RS51092B (sr) Escitalopram bromhidrat i postupak za njegovo pripremanje
WO2005000291A8 (en) Method for treatment of idiopathic pulmonary fibrosis using triptolide derivatives
MXPA04004075A (es) Compuesto y metodo para tratamiento de vejiga hiperactiva.
NO20073547L (no) Nikotinacetykolinreseptorligander
SE0203410D0 (sv) New use
WO2004058353A3 (en) Therapeutic use of selective noradrenaline reuptake inhibitors
MY136854A (en) Crystalline n-formyl hydroxylamine compounds